NL-OMON21668招募中不适用
Phase II study of sunitinib rechallenge in patients with metastatic renal cell carcinoma.
VU Medical Center0 个研究点目标入组 45 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 45
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Patients with histologically or cytologically confirmed clear-cell mRCC;
- •2. Patients who progressed on first-line treatment with sunitinib and who had clinical benefit defined as a response (according to RECIST 1.1 criteria) or SD for more than 6 months on this treatment;
排除标准
- •1. Patients treated with any VEGF targeted TKI (sorafenib, pazopanib, axitinib, dovitinib) as second-line treatment after progression on first-line sunitinib treatment;
- •2. Uncontrolled hypertension. Blood pressure must be ≤160/95 mmHg at the time of screening on a stable antihypertensive regimen. Blood pressure must be stable on at least 2 separate measurements on at least 2 separate days;
研究者
相似试验
进行中（未招募）
1 期
Retreatment with sunitinib in patients with metastatic (spread) kidney cancer.EUCTR2012-002891-15-NLVU University Medical Center45
已完成
2 期
Phase II study of sunitinib rechallenge in patients with metastatic renal cell carcinoma.NL-OMON41227Vrije Universiteit Medisch Centrum45
进行中（未招募）
1 期
Phase II study of sunitinib (SU011248) in patients with small cell lung cancer who are either chemo-naïve (extensive disease) or have a sensitive relapsePatients with small cell lung cancer who are either chemo-naïve (extensive disease) or have a sensitive relapse (extensive or limited disease).MedDRA version: 9.1Level: LLTClassification code 10041067Term: Small cell lung cancerEUCTR2006-002485-19-BEEORTC-European Organisation for Research and Treatment of Cancer48
尚未招募
2 期
Phase II study of sunitinib (SU011248) in patients with small cell lung cancer who are either chemo-naïve (extensive disease) or have a sensitive relapsesmall cell lung cancer1003866610029107NL-OMON33984European Organisation for Research in Treatment of Cancer (EORTC)20
进行中（未招募）
不适用
Phase II study of sunitinib (SU011248) in patients with small cell lung cancer who are either chemo-naïve (extensive disease) or have a sensitive relapsePatients with small cell lung cancer who are either chemo-naïve (extensive disease) or have a sensitive relapse (extensive or limited disease).MedDRA version: 9.1Level: LLTClassification code 10041067Term: Small cell lung cancerEUCTR2006-002485-19-DEEORTC-European Organisation for Research and Treatment of Cancer48